Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5564]

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric...

Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer ( Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China )

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative...

Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma ( Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong )

Physical activity reduces fatigue and improves quality of life in colorectal...

Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA

Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors ( Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA )

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric...

Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer ( Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada )

The human crisis in cancer: a Lancet Oncology Commission

Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada

The human crisis in cancer: a Lancet Oncology Commission ( Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada )

Mismatching of unrelated donors beyond a single HLA-locus does not adversely...

Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation ( Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA )

Post-treatment exercise programme improves survival for stage II/III colon...

Dr Christopher Booth - Queen's University, Kingston, Canada

Post-treatment exercise programme improves survival for stage II/III colon cancer ( Dr Christopher Booth - Queen's University, Kingston, Canada )

MS-553 shows promise in treating chronic lymphocytic leukaemia

Prof Jennifer Woyach - The Ohio State University, Columbus, USA

MS-553 shows promise in treating chronic lymphocytic leukaemia ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )

Key insights on breast cancer in Cape Verde

Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde

Key insights on breast cancer in Cape Verde ( Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde )

Addressing cancer control challenges in Africa

Dr Zainab Bagudu - MedicAid Cancer Foundation, Abuja, Nigeria

Addressing cancer control challenges in Africa ( Dr Zainab Bagudu - MedicAid Cancer Foundation, Abuja, Nigeria )

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and...

Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety ( Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA )

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML

Dr Akriti Jain - Cleveland Clinic, Cleveland, USA

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML ( Dr Akriti Jain - Cleveland Clinic, Cleveland, USA )

More from ecancer